Overview

Master the Necessary Skills to Rise to the Newfound Challenges of the Pharmaceutical Patent Endgame

ACI’s industry-leading Paragraph IV Disputes Master Symposium enters its fifth iteration this fall. This event will pick up where ACI Paragraph IV conference left off to bring you up-to-the minute information on the latest developments affecting ANDA litigation.

 

Preeminent patent litigators representing brand name and generic drug makers, leading in-house counsel, and esteemed jurists will provide insights on such matters as:

 

  • The impact of TC Heartland on jurisdiction and venue
  • The legal and business repercussions of Helsinn
  • Amgen v. Sandoz from an ANDA litigator’s point of view
  • The FDA Final MMA Rule
  • Novartis v. Noven and differing standards of review
  • Secondary considerations in obviousness reviews
  • Alternative forums: PTAB and ITC
  • Oil States vs. Greene’s Energy Group and the constitutionality of IPR proceedings
  • Exceptional case findings
  • Reverse payment settlements
  • Patent lawsuit risk assessment and other IP due diligence essentials

 

To learn more, download the agenda now.

 

Judicial Insights from: United States District Court

Honorable
Douglas E. Arpert
U.S.M.J.
United States District Court,District of New Jersey
Honorable
Ruben Castillo,
Chief Judge,
United States District Court Northern District of Illinois
Honorable
Stanley R. Chesler,
U.S.D.J
United States District Court District of New Jersey (Newark, NJ)
Honorable
Jose L. Linares
Chief Judge
United States District Court District of New Jersey
Honorable
Mary Pat Thynge
Chief Magistrate Judge,
United States District Court District of Delaware

 

Patent Trial and Appeal Board, USPTO

Honorable
Brian P. Murphy
Lead Administrative Patent Judge, Patent Trial and Appeal Board,
USPTO
Honorable
Michelle N. Ankenbrand
Lead Administrative Patent Judge, Patent Trial and Appeal Board
USPTO

 

In-house Insights from:

 

  • AbbVie
  • Akorn Pharmaceuticals
  • Amneal Pharmaceuticals
  • Astellas Pharma US, Inc.
  • Eagle Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Fresenius Kabi USA, LLC
  • Gilead Sciences, Inc.
  • Impax Laboratories
  • Otsuka
  • Sarepta Therapeutics

Don’t sit back while your competition gains valuable knowledge from this conference.
Register to secure your space now!

REGISTER NOW

 
Event Contacts
 

For questions about this year’s program/content, or information on how you can speak next year please contact:
Lisa Piccolo
Tel: 212.352.3220 ext. 5229
[email protected]

For sponsorship opportunities please contact:
Esther Fleischhacker
Tel: 212-352-3220 x5232
[email protected]

For media partnership opportunities please contact:
Linda Lam
Tel: 212-352-3220 ext. 5538
[email protected]

Venue

InterContinental Chicago Magnificent Mile

505 N. Michigan Avenue, Chicago, IL 60611
1-800-628-2112 or 1-312-944-4100

Accommodations:

The American Conference Institute is pleased to offer our delegates a limited number of hotel rooms at a preferential rate. To book a room at the discounted rate please call the number below and mention “ACI’s Advanced PIV Symposium” Alternatively, delegates can book online by entering the code “YEI” via the link below.

Room Rate: $299+tax, Executive Tower Guest Rooms
Room Cut-off: September 15, 2017

Book